ArticlePloS one2019

A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies.

Pierre Duquette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.